416 total citations 17 papers, 318 citations indexed
About
Wiesner Rh is a scholar working on Surgery, Hepatology and Transplantation.
According to data from OpenAlex, Wiesner Rh has authored 17 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 10 papers in Hepatology and 8 papers in Transplantation. Recurrent topics in Wiesner Rh's work include Organ Transplantation Techniques and Outcomes (12 papers), Renal Transplantation Outcomes and Treatments (8 papers) and Liver Diseases and Immunity (5 papers). Wiesner Rh is often cited by papers focused on Organ Transplantation Techniques and Outcomes (12 papers), Renal Transplantation Outcomes and Treatments (8 papers) and Liver Diseases and Immunity (5 papers). Wiesner Rh collaborates with scholars based in United States and Italy. Wiesner Rh's co-authors include J. Ludwig, Klintmalm Gb, Taswell Hf, Gerry McEntee, Erik Wahlström, Jorge Rakela, Moore Sb, D. H. Persing, Robert M. Goldstein and John R. Lake and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and American Journal of Kidney Diseases.
In The Last Decade
Wiesner Rh
17 papers
receiving
308 citations
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
This map shows the geographic impact of Wiesner Rh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wiesner Rh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wiesner Rh more than expected).
This network shows the impact of papers produced by Wiesner Rh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wiesner Rh. The network helps show where Wiesner Rh may publish in the future.
Co-authorship network of co-authors of Wiesner Rh
This figure shows the co-authorship network connecting the top 25 collaborators of Wiesner Rh.
A scholar is included among the top collaborators of Wiesner Rh based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Wiesner Rh. Wiesner Rh is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Rh, Wiesner, et al.. (1997). Twelve years of liver transplantation at the Mayo Clinic.. PubMed. 173–81.6 indexed citations
4.
Rh, Wiesner, et al.. (1996). Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b.. PubMed. 91(12). 2560–2.53 indexed citations
5.
Gb, Klintmalm, et al.. (1995). Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group.. PubMed. 27(1). 1114–6.20 indexed citations
Gb, Klintmalm, Robert M. Goldstein, Thomas A. Gonwa, et al.. (1993). Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.. PubMed. 25(1 Pt 1). 679–88.19 indexed citations
8.
Gb, Klintmalm, Robert M. Goldstein, Thomas A. Gonwa, et al.. (1993). Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.. PubMed. 25(1 Pt 1). 635–7.8 indexed citations
9.
Gb, Klintmalm, Robert M. Goldstein, Thomas A. Gonwa, et al.. (1993). Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.. PubMed. 25(1 Pt 1). 641–3.7 indexed citations
10.
Lazzarotto, Tiziana, et al.. (1992). Antibody response to cytomegalovirus (CMV) polypeptides in liver transplant recipients with CMV hepatitis.. PubMed. 15(1). 15–22.5 indexed citations
11.
Rh, Wiesner. (1991). Selective bowel decontamination for infection prophylaxis in liver transplantation patients.. PubMed. 23(3). 1927–8.10 indexed citations
12.
McEntee, Gerry, et al.. (1991). A comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis.. PubMed. 23(1 Pt 2). 1563–4.35 indexed citations
13.
Sb, Moore, et al.. (1990). Evidence that the liver does not always protect the kidney from hyperacute rejection in combined liver-kidney transplantation across a positive lymphocyte crossmatch.. PubMed. 50(2). 331–4.33 indexed citations
14.
Ludwig, J., et al.. (1990). The syndrome of primary sclerosing cholangitis.. PubMed. 9. 555–66.39 indexed citations
15.
Rakela, Jorge, et al.. (1987). Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantation.. PubMed. 19(1 Pt 3). 2399–402.48 indexed citations
16.
Rh, Wiesner, et al.. (1987). A comparison of azathioprine and cyclosporine in liver transplantation: a study of two personal series.. PubMed. 19(1 Pt 3). 2440–2.5 indexed citations
17.
Rh, Wiesner, et al.. (1987). Immunohistologic labeling of infiltrating T lymphocytes in hepatic allografts: a rejection indicator.. PubMed. 19(1 Pt 3). 2474–5.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.